Gene dosage sensitivity of a novel mutation in the intracellular domain of P0 associated with Charcot-Marie-Tooth disease type 1B

Shy, 2004, Phenotypic clustering in MPZ mutations, Brain, 127, 1, 10.1093/brain/awh048 Warner, 1996, Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas and congenital hypomyelination, Neuron, 17, 451, 10.1016/S0896-6273(00)80177-4 Ikegami, 1996, A novel homozygous mutation of the myelin P0 gene producing Dejerine-Sottas disease (Hereditary Motor and Sensory Neuropathy type III), Biochem Biophys Res Commun, 222, 107, 10.1006/bbrc.1996.0705 Pareyson, 1999, Charcot-Marie-Tooth disease type 2 and P0 gene mutations, Neurology, 52, 1110, 10.1212/WNL.52.5.1106-f Leal, 2003, Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ,P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family, Neurogenetics, 4, 191, 10.1007/s10048-003-0153-0 Fabrizi, 2001, A somatic and germline mosaic mutation in MPZ/P(0) mimics recessive inheritance of CMT1B, Neurology, 57, 101, 10.1212/WNL.57.1.101 Xu, 2001, Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination, J Cell Biol, 155, 439, 10.1083/jcb.200107114 Sander, 2000, Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies, J Neurol Neurosurg Psychiatry, 68, 483, 10.1136/jnnp.68.4.483 Martini, 1995, Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies, Nat Genet, 11, 281, 10.1038/ng1195-281 Wong, 1996, Dominant-negative effect on adhesion by myelin P0 protein truncated in its cytoplasmic domain, J Cell Biol, 134, 1531, 10.1083/jcb.134.6.1531